Optimizing antibiotic management for patients with acute appendicitis: A quality improvement study

Jason Beckermann1, Maria E Linnaus1, Hayden Swartz2

  • 1General and Trauma Surgery, Mayo Clinic Health System-Northwest Wisconsin region, Eau Claire, WI.

Surgery
|February 27, 2024
PubMed
Abstract

Insights

This study reduced piperacillin-tazobactam use for appendicitis by updating antibiotic orders and educating clinicians. Surgical site infection rates remained stable, demonstrating a successful quality improvement intervention.

Area of Science:

  • Infectious Diseases
  • Surgical Infections
  • Quality Improvement

Background:

  • Preoperative broad-spectrum antibiotics are standard for appendectomy but face scrutiny due to rising antibiotic resistance.
  • The use of piperacillin-tazobactam for acute appendicitis is a particular concern.
  • Developing strategies to optimize antibiotic use is crucial for patient outcomes and antimicrobial stewardship.

Purpose of the Study:

  • To decrease the use of piperacillin-tazobactam in uncomplicated acute appendicitis.
  • To maintain or decrease surgical site infection (SSI) rates following appendectomy.
  • To implement a quality improvement project focused on appropriate antibiotic selection.

Main Methods:

  • A multisite quality improvement project was conducted.
  • Intervention components included updating electronic health record orders and clinician education on antibiotic selection.
  • Outcomes were compared between the 6-month preintervention and 6-month postintervention periods.

Main Results:

  • Piperacillin-tazobactam use decreased significantly from 51.4% to 20.1% postintervention (P < .001).
  • Surgical site infection rates (superficial, deep, organ space) did not increase.
  • Rates of 30-day readmission, reoperation, and Clostridioides difficile infection remained similar between groups.

Conclusions:

  • The quality improvement intervention effectively reduced piperacillin-tazobactam administration for acute appendicitis.
  • This approach successfully lowered targeted antibiotic use without compromising surgical site infection rates.
  • The findings support optimizing antibiotic selection in appendicitis management to combat resistance.

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
80
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
140
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.5K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127